Trusted News Discovery Since 2008
{{/content}}
Oxford University Covid-19 vaccine ‘encouraging' for older age groups
Credit: IndiaTimes- Published on November 19, 2020
The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The findings published in ‘Lancet' on Thursday based on 560 healthy adult volunteers shows that the ChAdOx1 nCoV-19 vaccine is “safe and well...
Video credit: ABC Action News
Published on November 19, 2020 - 00:35
Oxford University vaccine results show strong immune response in older demographic
Oxford University this morning announced more promising news in the development of its COVID-19 vaccine. The results from Phase 2 of its AZD122 vaccine trial, published in the Lancet on Thursday, show that the vaccine is as effective for the older demographic as it is for the younger. Story: https://wfts.tv/3pM5mAe
You are here
💡 newsR Knowledge: Other News Mentions
Coronavirus disease 2019
Disease caused by severe acute respiratory syndrome coronavirus 2
University of Oxford
Collegiate research university in Oxford, England
AstraZeneca will cut deliveries of the Oxford COVID-19 vaccine to the European Union by 60% in the first quarter of the year, according to Reuters news agency.
Credit: Sky News - Published 6 hours ago
The Lancet
Peer-reviewed general medical journal
India's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the..
Credit: IndiaTimes - Published 14 hours ago
Even as a controversy rages over the safety of India’s first indigenous Covid-19 vaccine Covaxin after it was granted Emergency Use Authorisation (EUA) even as..
Credit: IndiaTimes - Published 19 hours ago
Related videos from verified sources
AstraZeneca, 3rd Major COVID-19 Vaccine, Shown to Be Effective and Cheaper 01:10
Credit: Wibbitz Top Stories - Published on November 23, 2020
How AstraZeneca COVID-19 Vaccine Compares To Moderna, Pfizer 02:09
Credit: WBZ CBS Boston - Published on November 23, 2020
Virologist welcomes news of 70% efficacy for Oxford vaccine 01:10
Credit: PA - Press Association STUDIO - Published on November 23, 2020
Related news from verified sources
The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those...
on November 19, 2020 • IndiaTimes
The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those...
on November 20, 2020 • Mid-Day